Lobbying disclosures · Lobbying report
DVA: second_quarter 2026 lobbying report
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program H.R. 8875, Improving Home Dialysis Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidne
Follow DVA- Became public
- Jul 20, 2026, 2:07 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 11:10 AM EST
Why this is connected
Exact legal-name match: DAVITA INC. (https://www.sec.gov/Archives/edgar/data/927066/).
Reported lobbying amounts
Expenses: $980,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/d22fd931-52f7-490e-b905-4cccf05cb168/","filing_uuid":"d22fd931-52f7-490e-b905-4cccf05cb168","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d22fd931-52f7-490e-b905-4cccf05cb168/print/","filing_document_content_type":"text/html","income":null,"expenses":"980000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Joelle Thornhill","dt_posted":"2026-07-20T14:07:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Pennsylvania Avenue, NW","registrant_address_2":"Suite 225","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":301232,"url":"https://lda.gov/api/v1/registrants/301232/","house_registrant_id":37766,"name":"DAVITA INC.","description":null,"address_1":"601 Pennsylvania Avenue, NW","address_2":"Suite 225","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOELLE THORNHILL","contact_telephone":"+1 202-478-8189","dt_updated":"2026-07-27T17:07:39.157252-04:00"},"client":{"id":180606,"url":"https://lda.gov/api/v1/clients/180606/","client_id":12,"name":"DAVITA INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program H.R. 8875, Improving Home Dialysis Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) Model","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54801,"prefix":"mrs","prefix_display":"MRS.","first_name":"JOELLE","nickname":null,"middle_name":"OISHI","last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65892,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"PHILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151828,"prefix":null,"prefix_display":null,"first_name":"ANDY","nickname":null,"middle_name":null,"last_name":"VARGAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program H.R. 8875, Improving Home Dialysis Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) Model","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54801,"prefix":"mrs","prefix_display":"MRS.","first_name":"JOELLE","nickname":null,"middle_name":"OISHI","last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65892,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"PHILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151828,"prefix":null,"prefix_display":null,"first_name":"ANDY","nickname":null,"middle_name":null,"last_name":"VARGAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to Veterans Affairs and dialysis H.R. 3944, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, provisions related to dialysis","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54801,"prefix":"mrs","prefix_display":"MRS.","first_name":"JOELLE","nickname":null,"middle_name":"OISHI","last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65892,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"PHILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151828,"prefix":null,"prefix_display":null,"first_name":"ANDY","nickname":null,"middle_name":null,"last_name":"VARGAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in DVA
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Oct 7, 2025$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 7, 2025 · Joint
- Jan 17, 2024$1K–$15K
Sen. Jerry Moran (R-KS)
$1K–$15K · Traded Dec 14, 2023 · disclosed Jan 17, 2024
- Jan 17, 2024$1K–$15K
Sen. Jerry Moran (R-KS)
$1K–$15K · Traded Dec 14, 2023 · disclosed Jan 17, 2024 · Spouse
- Jan 12, 2024$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded Dec 12, 2023 · disclosed Jan 12, 2024 · Joint
- Jul 14, 2023$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded Jun 12, 2023 · disclosed Jul 14, 2023 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.